Trastornos del movimiento

  1. Avilés Olmos, I. 1
  2. Villino, R. 2
  3. Martín Bastida, A. 1
  4. Espinoza, C. 2
  5. Rodríguez Oroz, M. Cruz 1
  1. 1 Departamento de Neurología. Clínica Universidad de Navarra. Pamplona. España Facultad de Medicina. Universidad de Navarra. Pamplona. España
  2. 2 Departamento de Neurología. Clínica Universidad de Navarra. Pamplona. España
Journal:
Medicine: Programa de Formación Médica Continuada Acreditado

ISSN: 0304-5412

Year of publication: 2023

Issue Title: Enfermedades del sistema nervioso (VII): Parkinson. Otros trastornos del movimiento

Series: 13

Issue: 76

Pages: 4481-4490

Type: Article

DIALNET GOOGLE SCHOLAR

More publications in: Medicine: Programa de Formación Médica Continuada Acreditado

Abstract

Movement disorders encompass nervous system abnormalities responsible for the onset of abnormal involuntary movements both due to an excess of movement (so-called hyperkinetic disorders, which include tics, chorea, dystonia, tremor, and myoclonus) and due to slow, reduced movement (so-called hypokinetic disorders, mainly Parkinsonian syndromes). In all of them, regardless of their cause, an abnormality occurs in the normal functioning of the motor pathway of the basal ganglia. Tremor is a rhythmic, oscillatory movement which, according to its presentation (rest, postural, or kinetic), frequency (Hz), and topographic distribution, is due to different causes which have clinical particularities and different treatment and prognoses. Myoclonus refers to sudden, brief muscle spasms due to a neuronal discharge that cannot be voluntarily suppressed. It has different etiologies and treatments according to the origin, distribution, and form of presentation. This update will describe these aspects of tremor and myoclonus.

Bibliographic References

  • Kötter R, Wickens J. Interactions of glutamate and dopamine in a computational model of the striatum. J Comput Neurosci. 1995;2(3):195-214.
  • Mitchell IJ, Clarke CE, Boyce S, Robertson RG, Peggs D, Sambrook MA. Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neuroscience. 1989;32(1):213-26.
  • Vila M, Levy R, Herrero MT, Ruberg M, Faucheux B, Obeso JA. Consequences of nigrostriatal denervation on the functioning of the basal ganglia in human and nonhuman primates: an in situ hybridization study of cytochrome oxidase subunit I mRNA. J Neurosci. 1997;17(2):765-73.
  • Wichmann T, Bergman H, DeLong MR. The primate subthalamic nucleus. III. Changes in motor behavior and neuronal activity in the internal pallidum induced by subthalamic inactivation in the MPTP model of parkinsonism. J Neurophysiol. 1994;72(2):521-30.
  • Gibb WR, Kilford L, Marsden CD. Severe generalised dystonia associated with a mosaic pattern of striatal gliosis. Mov Disord. 1992;7(3):217-23.
  • Bhatia KP, Bain P, Bajaj N, Elble RJ, Hallett M, Louis ED. Consensus Statement on the classification of tremors. from the task force on tremor of the International Parkinson and Movement Disorder Society. Movement Disorders. 2018;33(1):75-87.
  • Edwards M, Stamelou M, Quinn N, Bhatia K. Pakinson`s disease and other movement disorders. 2ª ed. Oxford University Press; 2016. P. 124-8.
  • Holtbernd F, Shah NJ. Imaging the pathophysiology of essential tremor—A systematic review. Vol. 12, Frontiers in Neurology. Frontiers Media S.A.; 2021.
  • Lenka A, Jankovic J. Tremor syndromes: An updated review. Front Neurol. 2021;12:684835.
  • Louis ED, Ferreira JJ. How common is the most common adult movement disorder? Update on the worldwide prevalence of essential tremor. Mov Disord. 2010;25:534-41.
  • Bain PG, Findley LJ, Thompson PD, Gresty MA, Rothwell JC, Harding AE. A study of hereditary essential tremor. Brain. 1994;117:805-24.
  • Haubenberger D, Hallett M. Essential Tremor. N Engl J Med. 2018;378(19):1802-10.
  • Stefansson H, Steinberg S, Petursson H, Gustafsson O, Gudjonsdottir IH, Jonsdottir GA. Variant in the sequence of the LINGO1 gene confers risk of essential tremor. Nat Genet. 2009;41:277-9.
  • Welton T, Cardoso F, Carr JA, Chan LL, Deuschl G, Jankovic J. Essential tremor. Nat Rev Dis Primers. 2021;7(1):83.
  • Raina GB, Cersosimo MG, Folgar SS, Giugni JC, Calandra C, Paviolo JP. Holmes tremor: Clinical description, lesion localization, and treatment in a series of 29 cases. Neurology. 2016;86(10):931-8.
  • Espay AJ, Aybek S, Carson A, Edwards MJ, Goldstein LH, Hallett M. Current concepts in diagnosis and treatment of functional neurological disorders. JAMA Neurol. 2018;75(9):1132-41.
  • Schwingenschuh P, Espay AJ. Functional tremor. J Neurol Sci. 2022;435:120208.
  • Obeso J, Viteri C, Rodríguez Oroz MC, Zamarbide I, Artieda J. Tratado de neurología clínica. 2 nd ed. Madrid: Editorial Médica Panamericana; 2002. p. 599-609.
  • Zarranz JJ, Agundez M. Neurología. 6 a ed. Barcelona: Elsevier; 2018; p. 461-6.
  • Caviness JN. Myoclonus. Continuum (Minneap Minn). 2019;25(4):1055-80.
  • Jiménez F, Piudo MR, Luquín M, Molina J. Tratado de los trastornos del movimiento. Fisiopatología de mioclonías. Madrid: SmithKline Beecham; 1998; p. 897-927
  • Pena AB, Caviness JN. Physiology-based treatment of myoclonus. Vol.17. Neurotherapeutics. Springer Science and Business Media Deutschland GmbH; 2020. p. 1665-80.
  • Jiménez F, Piudo MR, Luquín M, Molina J. Tratado de los trastornos del movimiento. Sd mioclónico. Madrid: SmithKline Beecham; 1998; p. 897-927.
  • Bhidayasiri R, Truong DD. Startle syndromes. Handb Clin Neurol. 2011;100:421-30.
Data source: Dialnet